	Controversies in NEN: An ENETS position statement on the role of liver transplantation (LT) in patients with advanced small-intestinal and pancreatic NETs. J Neuroendocrinol Stålberg P, McNamara MG, Grozinsky-Glasberg S, Pascher A, Kos-Kudla B, Denecke T, Begum N, Martin W, Alband S, Dromain C, Srirajaskanthan R, Baudin E. PMID: 42816382 [PubMed - indexed for MEDLINE]
	Schedule-dependent efficacy of gemcitabine and RAS(ON) inhibition in orthotopic pancreatic cancer: implications for clinical trial design. Cancer Lett Gribbin KP, Halamish H, Siordia IR, Finan JM, Pishvaian MJ, Lopez CD, Kardosh A, Goodyear S, Sears RC, Zimmers T, Grossberg A, Byrne KT, Brody JR. PMID: 42815683 [PubMed - as supplied by publisher]
	Trends in Cyst Size of Resected Intraductal Papillary Mucinous Neoplasms Over Time-Has the Evolution of the International Association of Pancreatology (IAP) Guidelines Impacted Surgical Thresholds. J Gastrointest Surg Wong P, Pollini T, Hernandez S, Todeschini L, Maker AV. PMID: 42815619 [PubMed - as supplied by publisher]
	Palliative Care for Advanced Cancer in Medicare Advantage and Physician Networks. JAMA Netw Open Hu X, Jiang C, Kwon Y, Fan Q, Shi KS, Zheng Z, Zhao J, Pollack CE, Blackford AL, Warren JL, Han X, Yabroff KR. PMID: 42814462 [PubMed - indexed for MEDLINE]
	(177)Lu-labeled amidoxime-functionalized biodegradable microspheres for transarterial radioembolization of hepatocellular carcinoma. Precis Radiat Oncol Liu X, Wang G, Zhao Z, Wang H, Chen H, Xu X, Li J, Ma H. PMID: 42812750 [PubMed - as supplied by publisher]
	Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives. Nat Commun Raufi AG, D'Souza EK, May MS, Sedycias S, Pellicciotta I, Pan S, Wang S, Palermo C, Sastra S, Sender N, Ross I, Li L, Luthria K, Shah P, Tagore S, Walsh ZH, Turk A, Sema B, Iuga A, Dajiang S, Kluger MD, Schrope BA, Brown D, Fojo T, Schvartzman JM, Pumpalova Y, Moy RH, Bates S, Wu L, Hibshoosh H, Tan AC, Schwartz GK, Chabot JA, Olive KP, Izar B, Manji GA. PMID: 42811017 [PubMed - indexed for MEDLINE]
	Interleukin-35 and pancreatic cancer: research progress from tumor-promoting mechanisms to treatment resistance. Cytokine Guo Y, Liang J, Liu X, Wang L, Li W, Song M, Wang X, Liu Y, Li Z, Li S, Fu N, Zhang B. PMID: 42810078 [PubMed - as supplied by publisher]
	Real-world implementation of a decision aid for treatment decisions in metastatic pancreatic cancer: a prospective multicenter study across expert centers. Oncologist Graus MUJE, Broekman THT, van Nassau S, Pepels-Aarts N, Cirkel GA, den Dulk M, Haberkorn BCM, van Hellemond IEG, Hermans KEPE, Homs MYV, Los M, Luelmo SAC, Mulder SF, Streppel MM, Wumkes ML, Wilmink JW, de Hingh IHJT, Valkenburg-van Iersel LBJ, de Vos-Geelen J, Dutch Pancreatic Cancer Group. PMID: 42809229 [PubMed - as supplied by publisher]
	Association between cachexia-associated diagnoses, health care resource utilization, and costs in patients with pancreatic, lung, and colorectal cancers: A US insurance claims database analysis. J Manag Care Spec Pharm Perkins K, Roth JA, Carlson J. PMID: 42808542 [PubMed - indexed for MEDLINE]
	Evaluation of Maintenance Capecitabine Therapy After First-Line Chemotherapy in Metastatic Pancreatic Cancer. Asian Pac J Cancer Prev Shehata MA, Alhanafy AM, Hassan ME, Shaaban NA, Hegazy AH. PMID: 42808386 [PubMed - indexed for MEDLINE]
	Engineering strategies to address immune and delivery barriers in pancreatic ductal adenocarcinoma: a barrier-matched translational framework. Front Immunol Li Y, Li Y, Fan J, San ZQ, Ye JF. PMID: 42807818 [PubMed - indexed for MEDLINE]
	Deep learning models for pancreatic cancer detection on CT: a meta-analysis. Front Med (Lausanne) Ding Y, Qin H, Qu Z, Ju J, Peng L. PMID: 42807151 [PubMed]
	Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection. Aliment Pharmacol Ther Park AJ, Pan BL, Pan X, Park J, Dong J, Pan CQ. PMID: 42806894 [PubMed - as supplied by publisher]
	Sweetened Beverages and Pancreatic Cancer: Insights From Recent Epidemiological Data and Oncogenic Mechanisms. Mol Nutr Food Res Mai HTT, Mirzaeva N, Dac DT, Nghia TT, Nguyen MAT, Espinoza JL. PMID: 42806724 [PubMed - indexed for MEDLINE]
	Efficacy and safety of adjuvant targeted therapy plus immunotherapy in hepatocellular carcinoma patients with high-risk recurrence factors after hepatectomy. Updates Surg Zhang M, Wang L, Man Z, Xu M. PMID: 42806231 [PubMed - as supplied by publisher]
	Repurposing Gastric Cancer Biomarkers for Mucinous Ovarian Carcinoma: ERBB2 and Claudin 18.2 as Therapeutic Targets. Int J Gynecol Pathol Wang S, De Boeck A, Kang EY, Meagher NS, Gorringe KL, Nelson GS, Lee CH, Minoo P, Köbel M. PMID: 42804804 [PubMed - as supplied by publisher]
	Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer. Expert Opin Biol Ther Kreidi J, Hoyek C, Eslinger C, Bekaii-Saab T. PMID: 42804710 [PubMed - as supplied by publisher]
	Second-Line Systemic Therapy Following First-Line FOLFIRINOX or NALIRIFOX in Metastatic Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Shaker P, Kamran D, Du L, Pant S, Rogers JE, Mizrahi JD. PMID: 42804027 [PubMed - indexed for MEDLINE]
	Recurrent Syncope, Behavioral Changes and Weight Gain in an Elderly Filipino Woman: Successful Diagnosis and Management of Insulinoma With 13-Year Disease-Free Follow-up. J ASEAN Fed Endocr Soc Canete E, Sandoval MA. PMID: 42802822 [PubMed - indexed for MEDLINE]
	VIPoma Presenting With Obstructive Jaundice: A Case Report. J ASEAN Fed Endocr Soc Ng SY, Chiew KS. PMID: 42802744 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 61693

Page 1 of 3085



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy